JHVEPhoto/iStock Editorial via Getty Images Labcorp ( NYSE: LH ) is reportedly considering ramping up its testing capacity for mpox amid a rising number of cases of the contagious disease. Labcorp ( LH ) processes around 500 tests a month for mpox, also known as monkeypox, but has the ability to scale up to approximately 25K a month. The company is working with US healthcare officials to determine if it needs to increase capacity, according to Reuters .
The World Health Organization recently declared mpox a public health emergency amid the emergence of a more contagious variant of the virus, which is related to smallpox. Other providers of mpox testing services or products include Quest Diagnostics ( DGX ), Roche ( OTCQX:RHHBY ) and Abbott ( ABT ). Co-Diagnostics ( CODX ) and Applied DNA Sciences ( APDN ).
More on Laboratory Corporation of America Labcorp Holdings Inc (LH) Q2 2024 Earnings Call Transcript Laboratory Corporation: Limited Upside Visibility, Reiterate Hold Laboratory Corporation of America beats top-line and bottom-line estimates; updates FY24 outlook Laboratory Corporation of America Q2 2024 Earnings Preview Seeking Alpha’s Quant Rating on Laboratory Corporation of America.